Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Relmada Therapeutics, Inc. (RLMD)

4.3250 -0.0050 (-0.12%)
As of 10:15:29 AM EDT. Market Open.
Trade RLMD on Coinbase
Chart Range Bar
Loading chart for RLMD
  • Previous Close 4.3300
  • Open 4.3100
  • Bid 3.2400 x 200
  • Ask 4.3400 x 200
  • Day's Range 4.3100 - 4.3700
  • 52 Week Range 1.0600 - 8.0000
  • Volume 135,412
  • Avg. Volume 1,732,679
  • Market Cap (intraday) 461.347M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9100
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.67

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

www.relmada.com

17

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RLMD
10.46%
S&P 500 (^GSPC)
12.13%

1-Year Return

RLMD
286.16%
S&P 500 (^GSPC)
18.81%

3-Year Return

RLMD
27.96%
S&P 500 (^GSPC)
70.28%

5-Year Return

RLMD
81.91%
S&P 500 (^GSPC)
69.71%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings -12.91M
Profit Margin 0.00%

Q1

FY25

Q3

FY25

Q4

FY25

Q2

FY26

-15M
-10M
-5M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

9.00
12.67 Average
4.3250 Current
19.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/18/2026
Analyst HC Wainwright & Co.
Rating Action Initiated
Rating Buy
Price Action Announces
Price Target 12

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    482.15M

  • Enterprise Value

    264.42M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.33

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -14.38%

  • Return on Equity (ttm)

    -25.62%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -15.01M

  • Diluted EPS (ttm)

    -0.9100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    116.44M

  • Total Debt/Equity (mrq)

    0.10%

  • Levered Free Cash Flow (ttm)

    -7.74M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.3250 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Insider Picks for 08/15/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 08/14/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 08/13/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 08/12/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: